Product Code: ETC071146 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The infectious disease biomarker testing market in Singapore has witnessed significant growth in recent years due to the rising prevalence of infectious diseases and the increasing demand for accurate and rapid diagnostic solutions. Biomarker testing plays a critical role in the early detection, diagnosis, and monitoring of infectious diseases, enabling timely treatment and effective disease management.
Increasing Incidence of Infectious Diseases: The prevalence of infectious diseases, such as viral and bacterial infections, continues to rise in Singapore. This has created a higher demand for reliable biomarker testing methods to facilitate early diagnosis and appropriate disease management.Advancements in Diagnostic Technologies: Technological advancements in the field of diagnostic testing have led to the development of more sensitive, specific, and rapid biomarker assays. These innovations have improved the accuracy and efficiency of infectious disease diagnostics, driving market growth.Growing Awareness and Healthcare Infrastructure: Increasing awareness of the importance of early disease detection and the presence of a well-developed healthcare infrastructure in Singapore have further boosted the adoption of infectious disease biomarker testing.Government Initiatives and Public Health Programs: The Singapore government`s proactive approach to combat infectious diseases through public health programs and initiatives has stimulated the demand for biomarker testing, as early diagnosis is crucial for disease control and prevention.
Cost Constraints: Some biomarker tests can be relatively expensive, making them less accessible to certain segments of the population, especially in resource-constrained settings.Regulatory Compliance: The infectious disease biomarker testing market is subject to rigorous regulatory standards to ensure the accuracy and safety of diagnostic products. Compliance with these regulations can be challenging for some manufacturers and may delay product approvals.Limited Access to Advanced Testing Facilities: Remote and underdeveloped areas in Singapore may have limited access to specialized laboratories equipped with advanced biomarker testing technologies, hindering timely and accurate diagnosis.
Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc. are the key players.
The Covid-19 pandemic had a profound impact on the infectious disease biomarker testing market in Singapore. The sudden outbreak of the virus led to an urgent need for widespread testing to identify and isolate infected individuals. The demand for Covid-19 diagnostic tests, including biomarker-based assays, soared during the pandemic, with both public and private sectors collaborating to enhance testing capacity.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Infectious Disease Biomarker Testing Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, 2020 & 2027F |
3.3 Singapore Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 Singapore Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2020 & 2027F |
3.6 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2020 & 2027F |
3.7 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2020 & 2027F |
4 Singapore Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Singapore Infectious Disease Biomarker Testing Market Trends |
6 Singapore Infectious Disease Biomarker Testing Market, By Types |
6.1 Singapore Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2018 - 2027F |
6.1.4 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2018 - 2027F |
6.1.5 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2018 - 2027F |
6.2 Singapore Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2018 - 2027F |
6.2.3 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2018 - 2027F |
6.2.4 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2018 - 2027F |
6.2.5 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2018 - 2027F |
6.2.6 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2018 - 2027F |
6.2.7 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2018 - 2027F |
6.3 Singapore Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2018 - 2027F |
6.3.3 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2018 - 2027F |
6.3.4 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2018 - 2027F |
6.3.5 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2018 - 2027F |
6.3.6 Singapore Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2018 - 2027F |
7 Singapore Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 Singapore Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 Singapore Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 Singapore Infectious Disease Biomarker Testing Market Key Performance Indicators |
9 Singapore Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 Singapore Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2020 & 2027F |
9.2 Singapore Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2020 & 2027F |
9.3 Singapore Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2020 & 2027F |
10 Singapore Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 Singapore Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2020 |
10.2 Singapore Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |